Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

Launched by NEURALIGHT · Jul 25, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new software platform called NeuraLight that uses eye-tracking technology to measure eye movements. Researchers want to see how well this system can collect data from healthy individuals and compare its results to a well-established eye-tracking system. The goal is to ensure that the NeuraLight system is effective and accurate in capturing important information about how our eyes move.

If you’re between 18 and 90 years old, have normal or corrected vision, and can follow instructions, you might be eligible to participate. However, you cannot have certain conditions, like a history of epilepsy or other neurological diseases. Participants will be asked to sit calmly for about 20 minutes while the eye-tracking technology is used. This study is currently recruiting individuals, so if you or someone you know is interested in helping to improve eye movement research, this could be a great opportunity!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women ages between 18 and 90 years old
• • Normal or corrected vision
• • Ability to follow instructions
• • Willing and able to sign an informed consent form
• Exclusion Criteria:
• • Inability to sit for 20 minutes on a chair in a calm manner
• • Personal or 1st degree relative history of epilepsy
• • Additional neurological diseases
• • Drug or alcohol abuse